Sirtex Medical receives AUD$1.9bn takeover offer from CDH Investments

By Thierry Boudan

Leading Australian medical company Sirtex Medical has announced that it has received a AUD$1.87bn (US$1.41bn) takeover offer from Chinese company CDH Investments.

The offer from CDH would see the Chinese firm paying AUD$33.6 per share for the liver cancer treatment specialist, equating to a 20.6% premium to the company’s unaffected share price.

See also:

The news puts pressure on cancer treatment company Varian’s existing takeover attempt, with its own offer made in January standing at AUD$310mn less than CDH’s new offer.

However, statements from both Sirtex and Varian suggest that the Australian firm will continue to pursue the existing takeover arrangement, despite the higher offer from CDH.

“At this time, the directors of Sirtex continue to believe the existing scheme of arrangement with Varian is in the best interests of Sirtex shareholders and continue to unanimously support and recommend the Scheme,” Sirtex said.

“The Varian Scheme has been unanimously approved by both boards of directors, has fully committed financing and has received all necessary regulatory approvals. We believe the Varian Scheme offers more value and carries far less risk for Sirtex stockholders,” Varian said.

Sirtex also revealed that a takeover by CDH would need approval of Australia’s Foreign Investment Review Board.

Share

Featured Articles

Top 10 female executives leading Japan's charge for change

As Japan pledges a 30% target for women executives at big firms by 2030, we spotlight 10 female corporate leaders blazing a trail in the country

Top 10 most valuable unicorns in China – phones to drones

Home to the world’s most valuable unicorn, not to mention the fastest growing, China may be trailing the US on numbers, but it is catching up – and fast

Top 10 fastest-growing energy companies in the APAC region

Business Chief takes a look at the top 10 fastest-growing energy companies in the APAC region, according to rankings from S&P Global Commodity Insights

Top 10 Chief Financial Officers in India

Corporate Finance

Top 10 largest companies Malaysia and the CEOs who helm them

Leadership & Strategy

5 high-profile CEO moves across Asia-Pacific this month

Leadership & Strategy